Ebitda تغيير تاريخ
AbbVie USD 6.91B 3.22B 2026-06
Amgen USD 4.55B 696M 2026-06
AstraZeneca USD 7.46B 2.3B 2026-09
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Canopy Growth CAD 8M 145M 2026-06
Corcept Therapeutics USD 42.16M 91.17M 2026-06
Drreddys Laboratories INR 18.79B 10.16B 2026-09
Eli Lilly USD 9.46B 3.54B 2026-09
Genmab DKK 401M 186M 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
Glaxosmithkline GBP 2.93B 154M 2026-09
J&J USD 8.99B 721M 2026-06
Lakefront Biotherapeutics EUR -63.7M 624.2M 2026-03
Merck USD 1.42B 2.97B 2026-06
Novartis USD 8.62B 2.14B 2026-09
Novartis USD 5.36B 45M 2026-09
Pacira USD 48.67M 8.43M 2026-06
Perrigo USD 141.6M 1.34B 2026-03
Pfizer USD 6.01B 18M 2026-06
Phibro Animal Health USD 68.1M 6.2M 2025-12
Prestige Brands USD 61.24M 23.31M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 5.79B 2.1B 2026-09
Sanofi EUR 6.66B 4.99B 2026-09
Supernus Pharmaceuticals USD 55.6M 24M 2026-09
UCB EUR 1.6B 570M 2025-12
Zoetis USD 939M 0 2026-03